-The Hindu Business Line The gel, poly-Oxime has been prepared by InStem researchers from nucleophilic polymer New Delhi: Indian farmers usually do not wear any protective gear while spraying chemicals in fields. This exposes them to harmful toxics contained in pesticides, causing severe health impacts and even death in extreme cases. Indian scientists have now developed a protective gel to address this problem. The gel can be applied on skin and can break...

-The Telegraph Glare on late diagnosis and poor management New Delhi: Delayed diagnosis, poor chronic disease management skills and faith in unproven traditional-medicine therapies are barriers to the effective treatment of diabetes in India and other South Asian countries, a group of doctors has cautioned. A seven-member team from academic institutions and hospitals in India, Britain and Australia has said an improvement in doctors’ skills and the release of updated diabetes management...

-Press release by Right to Food Campaign dated 28th September, 2018 17 lakh elderly, widows and differently-abled persons in Jharkhand who qualify for social security pensions, do not receive their entitlement. One important reason is that pension coverage in Jharkhand is not universal. Even those who do receive pensions face chronic selection errors and administrative glitches. In 2016-17, 3 lakh pensioners were deleted as “fake”, though many genuine persons, whose pension...

-The Hindu Business Line A campaign and fundraiser are trying to persuade farmers in Haryana and Punjab to opt for technology instead of using the polluting method of crop stubble burning in the sowing season this winter October-November are the cruellest months for people living in the National Capital Region. A heavy smog slowly drifts in and hangs in through the winter, sending particulate matter (PM) levels soaring to a hazardous degree....

-The Telegraph New Delhi: Patients' rights advocates in India on Tuesday filed two oppositions in the Indian patent office, challenging patent claims by the US pharmaceutical company Gilead Sciences for its medicines sofosbuvir and velpatasvir, used to treat hepatitis-C infections. The oppositions filed by the Delhi Network of Positive People (DNP+) challenge Gilead's patent applications for the tablet formulations of the fixed dose combination of sofosbuvir and velpatasvir and a new form...